Novozymes A/S

Copenhagen Stock Exchange NSIS-B.CO

Novozymes A/S Market Capitalization on January 14, 2025: USD 25.15 B

Novozymes A/S Market Capitalization is USD 25.15 B on January 14, 2025, a 0.54% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
  • Novozymes A/S 52-week high Market Capitalization is USD 33.43 B on September 30, 2024, which is 32.93% above the current Market Capitalization.
  • Novozymes A/S 52-week low Market Capitalization is USD 23.41 B on January 18, 2024, which is -6.89% below the current Market Capitalization.
  • Novozymes A/S average Market Capitalization for the last 52 weeks is USD 28.04 B.
Key data
Date Market Capitalization Share Price Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S)
Market news
Loading...
Copenhagen Stock Exchange: NSIS-B.CO

Novozymes A/S

CEO Ms. Ester Baiget
IPO Date Nov. 20, 2000
Location Denmark
Headquarters Krogshoejvej 36
Employees 10,452
Sector Health Care
Industries
Description

Novozymes A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally. The company offers protein solutions for the food and beverage industry. It also offers industrial hygiene, drain openers, hard surface, medical cleaning, septic tanks, ware washing, and professional laundry services. In addition, the company provides dishwashing, softener, microbial and medical cleaning services. Further, it provides corn, cotton, forages, peanuts, pulses, soybeans, wheat, small grains, bioyield, and biocontrol solutions; warm water species, recirculating aquaculture system; animal health and nutrition solutions; fiber modification, bleach boosting, deposit control, and starch modification solutions. Additionally, the company provides carbon capture, leather and textiles solutions; enzyme solutions, including corn and wheat separation, liquefaction, saccharification, filtration, isomerization, maltose, and specialties solutions; warm water species and recirculating aquaculture system solutions; human health solutions, comprising brain, oral, protective and immune, and gastrointestinal health solutions; ethanol, biodiesel, renewable diesel, education, wastewater, and sewage sludge, and renewable diesel solutions; agriculture and industry, biogas food waste, food waste, biocatalysis, cell culture, diagnostics, enzyme, and biogas solutions. Furthermore, it provides lipases, proteases, oxidoreductases, and carbohydrases. Novozymes A/S was founded in 1925 and is based in Bagsvaerd, Denmark.

StockViz Staff

January 15, 2025

Any question? Send us an email